
For this Mother’s Day, Caroline Carney, MD, MSc, FAPM, CPHQ, explains the importance of understanding the correlation between mental health and heart health in women aged 65 years and older.
For this Mother’s Day, Caroline Carney, MD, MSc, FAPM, CPHQ, explains the importance of understanding the correlation between mental health and heart health in women aged 65 years and older.
The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
Previous studies found breastfeeding does not impact executive function or memory, which was similar to the findings in this study, according to the authors.
Preliminary study results showed no safety concerns among pregnant women that received Pfizer-BioNTech and Moderna COVID-19 vaccines.
Women who had migraines before menopause had a 29% increased risk of developing high blood pressure after menopause.
Researchers from the University of Pennsylvania School of Medicine have identified additional genetic mutations that strongly predispose otherwise healthy women to peripartum cardiomyopathy (PPCM), a rare condition characterized by weakness of the heart muscle that begins sometime during the final month of pregnancy through 5 months after delivery.
According to the study authors, the findings suggest a need for greater transparency in health care pricing as well as policies eliminating financial obstacles to catching cancer early.
The study highlights a new role for pregnancy-associated plasma protein A, known as PAPPA, in gestational diabetes, with translational potential as both a diagnostic tool and therapeutic target.
The risk peaks close to delivery and then improves by 1 year after delivery, though a modest risk of developing kidney stones continues beyond 1 year after delivery.
There have now been approximately 70,000 pregnant people vaccinated against COVID-19 with no evidence of harm.
The study suggests that the effects of job strain and social strain on women have a powerful health impact, with both being associated with a 21% higher risk of developing CHD.
A new study shows that overweight breast cancer survivors have a statistically significant increased risk of developing second primary cancers, and obesity is strongly associated with an increased risk of various cancer types.
Pharmacists may provide nutritional counseling regarding dietary adjustments or recommendations for over-the-counter supplements to assist patient with cancer.
Guidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.
Hager Hanon, PharmD, RPh, senior pharmacist at Community Care Rx, discusses COVID-19 vaccination hesitancy among pregnant women and people with a history of anaphylaxis.
Being diagnosed with diabetes does not make a person more likely to use effective contraception and may actually lead to a drop in the use of certain types of effective contraception.
Addressing sleep symptoms during menopause may reduce susceptibility to weight gain.
Women with obesity and polycystic ovarian syndrome (PCOS) have an increased risk of developing type 2 diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.
The analysis found that more than twice as many women who received olaparib were still alive 5 years after the beginning of the study with no progression of their cancer.
Although childbirth remains a difficult, often stressful experience for mothers, the advent of opioid medications for labor pain relief and the use of appropriate sanitation methods has made childbirth far safer for mothers than was possible during previous periods in history.
DKN-01 is a humanized monoclonal antibody that binds to and blocks the activity of the Dickkopf-1 (DKK1) protein, which activates the innate immune system in the tumor microenvironment and anti-tumor activity.
Fractures, especially subsequent ones, positively correlate with an increased mortality risk.
Results from the phase 3 KEYNOTE-775/study 309 trial found that Keytruda plus Lenvima reduced risk of death by 38%, with a median overall survival of 18.3 months
The researchers analyzed body composition data from the National Health and Nutrition Examination Survey (1999-2004) and cardiovascular disease data from the National Health and Nutrition Examination Survey (1999-2014).
The company received Fast Track designation from the FDA for GEN-1, a DNA-mediated interleukin-12 (IL-12) immunotherapy.